Your browser doesn't support javascript.
loading
SOX4: Epigenetic regulation and role in tumorigenesis.
Hanieh, Hamza; Ahmed, Emad A; Vishnubalaji, Radhakrishnan; Alajez, Nehad M.
Afiliación
  • Hanieh H; Biological Sciences Department, College of Science, King Faisal University, Hofuf, Saudi Arabia; Department of Biological Sciences, College of Science, Al-Hussein Bin Talal University, Ma'an, Jordan. Electronic address: hhanieh@kfu.edu.sa.
  • Ahmed EA; Biological Sciences Department, College of Science, King Faisal University, Hofuf, Saudi Arabia; Lab of Immunology and Molecular Physiology, Zoology Department, Faculty of Science, Assiut University, Assiut, Egypt.
  • Vishnubalaji R; Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.
  • Alajez NM; Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.
Semin Cancer Biol ; 67(Pt 1): 91-104, 2020 12.
Article en En | MEDLINE | ID: mdl-31271889
ABSTRACT
Sex-determining region Y-related (SRY) high-mobility group box 4 (SOX4) is a member of the group C subfamily of SOX transcription factors and promotes tumorigenesis by endowing cancer cells with survival, migratory, and invasive capacities. Emerging evidence has highlighted an unequivocal role for this transcription factor in mediating various signaling pathways involved in tumorigenesis, epithelial-to-mesenchymal transition (EMT), and tumor progression. During the last decade, numerous studies have highlighted the epigenetic interplay between SOX4-targeting microRNAs (miRNAs), long noncoding RNAs (lncRNAs) and SOX4 and the subsequent modulation of tumorigenesis, invasion and metastasis. In this review, we summarize the current state of knowledge about the role of SOX4 in cancer development and progression, the epigenetic regulation of SOX4, and the potential utilization of SOX4 as a diagnostic and prognostic biomarker and its depletion as a therapeutic target.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Epigénesis Genética / Factores de Transcripción SOXC / Carcinogénesis / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Semin Cancer Biol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Epigénesis Genética / Factores de Transcripción SOXC / Carcinogénesis / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Semin Cancer Biol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article